Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00528034 · ClinicalTrials.gov registry record · NA
Lymphoscintigraphy in Patients With Vaginal Cancer
A NA study of Vaginal Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT00528034: Completed NA study of Vaginal Cancer, sponsored by M.D. Anderson Cancer Center.
NCT00528034 is a NA study of Vaginal Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 14 participants, below the 602-participant average among 11 other Vaginal Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00528034, a NA study of Vaginal Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objectives: 1. Determine the feasibility of using pretreatment lymphoscintigraphy to identify the sentinel lymph node(s) in patients with vaginal cancer dispositioned to receive radiation therapy. 2. Determine the feasibility of using preoperative lymphoscintigraphy and intraoperative lymphatic mapping to identify the sentinel lymph node(s) in patients with vaginal cancer dispositioned to undergo surgery and bilateral lymph node dissection.
Conditions Studied
Interventions
- PROCEDURE Lymphoscintigraphy
Study Locations (1)
Texas
- U.T.M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2002-09 |
| Est. Completion | 2008-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00528034
The ClinicalTrials.gov registry entry for NCT00528034 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 602-participant average among 11 other Vaginal Cancer trials with a reported enrollment target (98% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vaginal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Lymphoscintigraphy is the first listed.
NCT00528034 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00528034 about?
NCT00528034 is a clinical study titled "Lymphoscintigraphy in Patients With Vaginal Cancer". Primary Objectives: 1. Determine the feasibility of using pretreatment lymphoscintigraphy to identify the sentinel lymph node(s) in patients with vaginal cancer dispositioned to receive radiation therapy. 2. Determine the feasibility of using preoperative lymphoscintigraphy and intraoperative lymph...
What is the current status of trial NCT00528034?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2002-09. Estimated completion is 2008-05.
What conditions does trial NCT00528034 study?
This clinical trial studies the following conditions: Vaginal Cancer.
What interventions are being tested in trial NCT00528034?
The interventions under investigation include: Lymphoscintigraphy (PROCEDURE).
Who is sponsoring clinical trial NCT00528034?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00528034 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaginal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
Image-Guided Gynecologic Brachytherapy
RECRUITING · NA
-
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
COMPLETED · NA
-
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RECRUITING · Phase 2
-
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
RECRUITING · Phase 2
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.